In the ever-evolving landscape of pharmaceuticals and biotechnology, chromatography remains one of the most critical analytical tools. From drug discovery and quality control to biologics manufacturing and vaccine development, chromatography enables scientists to separate, identify, and purify complex mixtures with unmatched precision.
As the demand for high-purity drugs, biotherapeutics, and personalized medicine increases, the global chromatography market is experiencing robust growth. Coupled with technological innovation and regulatory pressures for quality assurance, chromatography is becoming a cornerstone of the life sciences sector.
According to BCC Research, the global market for chromatography in pharmaceuticals and biotechnology is estimated to grow from $13.3 billion in 2025 to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.
The global market for chromatography in pharmaceuticals and biotechnology is projected to grow steadily over the next decade. This growth is driven by:
The market includes various techniques such as liquid chromatography (LC), gas chromatography (GC), high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and affinity chromatography, each tailored for specific molecules and applications.